Polar Securities »

Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Polar Securities

Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Polar Securities from 13F filings

Historical chart of Polar Securities investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Polar Securities consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Polar Securities

Quarter filed Position value Share count Share price at filing
2023-09-30 $33M 35M 0.93

More positions owned by Polar Securities

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Invesco Qqq Tr Unit Ser 1 Put Option (QQQ)
Sprott Asset Management Physical Gold Tr (PHYS)
Interdigital Note 3.500% 6/0 (Principal)
Live Nation Entertainment In Note 3.125% 1/1 (Principal)
NVIDIA Corporation (NVDA)
Home Depot (HD)
Axon Enterprise Note 0.500%12/1 (Principal)
Granite Constr Note 3.750% 5/1 (Principal)
Apple (AAPL)
Verona Pharma Sponsored Ads (VRNA)
Broadcom (AVGO)
Itron Note 1.375% 7/1 (Principal)
Tesla Motors (TSLA)
Arista Networks Com Shs (ANET)

View all positions for Polar Securities

Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1

Ing Investment Management
Bnp Paribas Arbitrage, Snc
State Street Corporation
Manufacturers Life Insurance Company
FMR
MacKay Shields
LMR Partners
Parallax Volatility Advisers
BlackRock
Lord, Abbett & Co
Universal- Beteiligungs- und Servicegesellschaft mbH
SSI Investment Management
Jpmorgan Chase & Co
Nicholas Investments Partners
State of Wisconsin Investment Board

View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1